Traws Pharma, Inc.
TRAW
$2.16
-$0.32-12.90%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 53.25% | 99.26% | 531.27% | -615.15% | -78.84% |
| Total Depreciation and Amortization | 650.00% | -75.00% | -75.00% | -50.00% | -60.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -59.77% | -100.03% | -8,013.51% | 7,361.45% | -4.72% |
| Change in Net Operating Assets | 93.96% | -10.25% | -359.46% | 290.38% | -3,422.11% |
| Cash from Operations | 65.05% | 39.31% | -22.90% | 8.80% | -156.79% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -76.72% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -77.89% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | 1,033.33% | 428.57% | -228.57% | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 41.96% | -675.81% | -21.89% | 460.12% | -155.88% |